サマリー

ホスホジエステラーゼ（PDE）阻害剤の世界市場 2024-2028
ホスホジエステラーゼ（PDE）阻害剤市場は、2023年から2028年にかけて37億8000万米ドルの成長が予測され、予測期間中のCAGRは6.85%で加速すると予測されます。当レポートでは、ホスホジエステラーゼ（PDE）阻害剤市場について、市場規模や予測、動向、成長促進要因、課題などの全体的な分析に加え、約25のベンダーを網羅したベンダー分析を掲載しています。
当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。同市場は、生活習慣の悪化、EDの蔓延、次世代PDE阻害剤の利用可能性などが牽引しています。
Technavio社のホスホジエステラーゼ（PDE）阻害剤市場は以下のように分類されます：
用途別
- 経口剤
- 外用薬
- その他RoA
タイプ別
- PDE5阻害剤
- PDE4阻害剤
- PDE3その他
地域別
- 北米
- 欧州
- アジア
- その他の地域（ROW）
本調査では、PDE阻害剤開発のための新技術の応用が、今後数年間のホスホジエステラーゼ（PDE）阻害剤市場の成長を促進する主要な理由の1つであると特定している。また、老年人口の増加と慢性疾患の負担増は、市場の大きな需要につながると考えられます。
この調査レポートは、ホスホジエステラーゼ（PDE）阻害薬市場を調査・分析し、以下のてこ入れを行った：
- ホスホジエステラーゼ（PDE）阻害剤市場のサイジング
- ホスホジエステラーゼ（PDE）阻害剤市場の予測
- ホスホジエステラーゼ（PDE）阻害剤市場の産業分析
本レポートでは、ホスホジエステラーゼ（PDE）阻害剤市場の主要ベンダーの詳細な分析を掲載しています。主要ベンダーには、AbbVie Inc.、Amgen Inc.、AstraZeneca Plc、Bayer AG、Boehringer Ingelheim International GmbH、Deciphera Pharmaceuticals Inc.、Dong A Socio Holdings Co.Ltd.、Dr Reddys Laboratories Ltd.、Eli Lilly and Co.、GlaxoSmithKline Plc.、Merck KGaA、Novartis AG、Pfizer Inc.、Sanofi SA、Sun Pharmaceutical Industries Ltd.、Teva Pharmaceutical Industries Ltd.、United Therapeutics Corp.、Viatris Inc.、VIVUS LLC、およびZydus Lifesciences Ltd.。また、ホスホジエステラーゼ（PDE）阻害剤市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/phosphodiesterase-pde-inhibitors-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global phosphodiesterase (PDE) inhibitors market 2018 - 2022
o Exhibit 18: Historic Market Size - Data Table on global phosphodiesterase (pde) inhibitors market 2018 - 2022 ($ billion)
o 4.2 Application Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
o 4.3 Type Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Application
o 6.1 Market segments
o Exhibit 30: Chart on Application - Market share 2023-2028 (%)
o Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
o 6.2 Comparison by Application
o Exhibit 32: Chart on Comparison by Application
o Exhibit 33: Data Table on Comparison by Application
o 6.3 Oral - Market size and forecast 2023-2028
o Exhibit 34: Chart on Oral - Market size and forecast 2023-2028 ($ billion)
o Exhibit 35: Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
o Exhibit 36: Chart on Oral - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Oral - Year-over-year growth 2023-2028 (%)
o 6.4 Topical - Market size and forecast 2023-2028
o Exhibit 38: Chart on Topical - Market size and forecast 2023-2028 ($ billion)
o Exhibit 39: Data Table on Topical - Market size and forecast 2023-2028 ($ billion)
o Exhibit 40: Chart on Topical - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Topical - Year-over-year growth 2023-2028 (%)
o 6.5 Other RoA - Market size and forecast 2023-2028
o Exhibit 42: Chart on Other RoA - Market size and forecast 2023-2028 ($ billion)
o Exhibit 43: Data Table on Other RoA - Market size and forecast 2023-2028 ($ billion)
o Exhibit 44: Chart on Other RoA - Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on Other RoA - Year-over-year growth 2023-2028 (%)
o 6.6 Market opportunity by Application
o Exhibit 46: Market opportunity by Application ($ billion)
o Exhibit 47: Data Table on Market opportunity by Application ($ billion)
• 7 Market Segmentation by Type
o 7.1 Market segments
o Exhibit 48: Chart on Type - Market share 2023-2028 (%)
o Exhibit 49: Data Table on Type - Market share 2023-2028 (%)
o 7.2 Comparison by Type
o Exhibit 50: Chart on Comparison by Type
o Exhibit 51: Data Table on Comparison by Type
o 7.3 PDE5 inhibitors - Market size and forecast 2023-2028
o Exhibit 52: Chart on PDE5 inhibitors - Market size and forecast 2023-2028 ($ billion)
o Exhibit 53: Data Table on PDE5 inhibitors - Market size and forecast 2023-2028 ($ billion)
o Exhibit 54: Chart on PDE5 inhibitors - Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on PDE5 inhibitors - Year-over-year growth 2023-2028 (%)
o 7.4 PDE4 inhibitors - Market size and forecast 2023-2028
o Exhibit 56: Chart on PDE4 inhibitors - Market size and forecast 2023-2028 ($ billion)
o Exhibit 57: Data Table on PDE4 inhibitors - Market size and forecast 2023-2028 ($ billion)
o Exhibit 58: Chart on PDE4 inhibitors - Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on PDE4 inhibitors - Year-over-year growth 2023-2028 (%)
o 7.5 PDE3 and others - Market size and forecast 2023-2028
o Exhibit 60: Chart on PDE3 and others - Market size and forecast 2023-2028 ($ billion)
o Exhibit 61: Data Table on PDE3 and others - Market size and forecast 2023-2028 ($ billion)
o Exhibit 62: Chart on PDE3 and others - Year-over-year growth 2023-2028 (%)
o Exhibit 63: Data Table on PDE3 and others - Year-over-year growth 2023-2028 (%)
o 7.6 Market opportunity by Type
o Exhibit 64: Market opportunity by Type ($ billion)
o Exhibit 65: Data Table on Market opportunity by Type ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 69: Chart on Geographic comparison
o Exhibit 70: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2023-2028
o Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.4 Europe - Market size and forecast 2023-2028
o Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 Germany - Market size and forecast 2023-2028
o Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
o 9.9 UK - Market size and forecast 2023-2028
o Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ billion)
o Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
o Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
o 9.10 China - Market size and forecast 2023-2028
o Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
o 9.11 France - Market size and forecast 2023-2028
o Exhibit 103: Chart on France - Market size and forecast 2023-2028 ($ billion)
o Exhibit 104: Data Table on France - Market size and forecast 2023-2028 ($ billion)
o Exhibit 105: Chart on France - Year-over-year growth 2023-2028 (%)
o Exhibit 106: Data Table on France - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 107: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 112: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 113: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 12.3 Amgen Inc.
o Exhibit 115: Amgen Inc. - Overview
o Exhibit 116: Amgen Inc. - Product / Service
o Exhibit 117: Amgen Inc. - Key offerings
o 12.4 AstraZeneca Plc
o Exhibit 118: AstraZeneca Plc - Overview
o Exhibit 119: AstraZeneca Plc - Product / Service
o Exhibit 120: AstraZeneca Plc - Key news
o Exhibit 121: AstraZeneca Plc - Key offerings
o 12.5 Bayer AG
o Exhibit 122: Bayer AG - Overview
o Exhibit 123: Bayer AG - Business segments
o Exhibit 124: Bayer AG - Key news
o Exhibit 125: Bayer AG - Key offerings
o Exhibit 126: Bayer AG - Segment focus
o 12.6 Boehringer Ingelheim International GmbH
o Exhibit 127: Boehringer Ingelheim International GmbH - Overview
o Exhibit 128: Boehringer Ingelheim International GmbH - Business segments
o Exhibit 129: Boehringer Ingelheim International GmbH - Key news
o Exhibit 130: Boehringer Ingelheim International GmbH - Key offerings
o Exhibit 131: Boehringer Ingelheim International GmbH - Segment focus
o 12.7 Dong A Socio Holdings Co. Ltd.
o Exhibit 132: Dong A Socio Holdings Co. Ltd. - Overview
o Exhibit 133: Dong A Socio Holdings Co. Ltd. - Product / Service
o Exhibit 134: Dong A Socio Holdings Co. Ltd. - Key offerings
o 12.8 Dr Reddys Laboratories Ltd.
o Exhibit 135: Dr Reddys Laboratories Ltd. - Overview
o Exhibit 136: Dr Reddys Laboratories Ltd. - Business segments
o Exhibit 137: Dr Reddys Laboratories Ltd. - Key offerings
o Exhibit 138: Dr Reddys Laboratories Ltd. - Segment focus
o 12.9 Eli Lilly and Co.
o Exhibit 139: Eli Lilly and Co. - Overview
o Exhibit 140: Eli Lilly and Co. - Product / Service
o Exhibit 141: Eli Lilly and Co. - Key news
o Exhibit 142: Eli Lilly and Co. - Key offerings
o 12.10 GlaxoSmithKline Plc
o Exhibit 143: GlaxoSmithKline Plc - Overview
o Exhibit 144: GlaxoSmithKline Plc - Business segments
o Exhibit 145: GlaxoSmithKline Plc - Key news
o Exhibit 146: GlaxoSmithKline Plc - Key offerings
o Exhibit 147: GlaxoSmithKline Plc - Segment focus
o 12.11 Pfizer Inc.
o Exhibit 148: Pfizer Inc. - Overview
o Exhibit 149: Pfizer Inc. - Product / Service
o Exhibit 150: Pfizer Inc. - Key news
o Exhibit 151: Pfizer Inc. - Key offerings
o 12.12 Sanofi SA
o Exhibit 152: Sanofi SA - Overview
o Exhibit 153: Sanofi SA - Business segments
o Exhibit 154: Sanofi SA - Key news
o Exhibit 155: Sanofi SA - Key offerings
o Exhibit 156: Sanofi SA - Segment focus
o 12.13 Sun Pharmaceutical Industries Ltd.
o Exhibit 157: Sun Pharmaceutical Industries Ltd. - Overview
o Exhibit 158: Sun Pharmaceutical Industries Ltd. - Product / Service
o Exhibit 159: Sun Pharmaceutical Industries Ltd. - Key offerings
o 12.14 Teva Pharmaceutical Industries Ltd.
o Exhibit 160: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 161: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 162: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 163: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 164: Teva Pharmaceutical Industries Ltd. - Segment focus
o 12.15 United Therapeutics Corp.
o Exhibit 165: United Therapeutics Corp. - Overview
o Exhibit 166: United Therapeutics Corp. - Product / Service
o Exhibit 167: United Therapeutics Corp. - Key offerings
o 12.16 Viatris Inc.
o Exhibit 168: Viatris Inc. - Overview
o Exhibit 169: Viatris Inc. - Business segments
o Exhibit 170: Viatris Inc. - Key news
o Exhibit 171: Viatris Inc. - Key offerings
o Exhibit 172: Viatris Inc. - Segment focus
o 12.17 Zydus Lifesciences Ltd.
o Exhibit 173: Zydus Lifesciences Ltd. - Overview
o Exhibit 174: Zydus Lifesciences Ltd. - Business segments
o Exhibit 175: Zydus Lifesciences Ltd. - Key offerings
o Exhibit 176: Zydus Lifesciences Ltd. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 177: Inclusions checklist
o Exhibit 178: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 179: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 180: Research methodology
o Exhibit 181: Validation techniques employed for market sizing
o Exhibit 182: Information sources
o 13.5 List of abbreviations
o Exhibit 183: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global phosphodiesterase (pde) inhibitors market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Application - Market share 2023-2028 (%)
Exhibits31: Data Table on Application - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Oral - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Topical - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Topical - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Topical - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Topical - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Other RoA - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on Other RoA - Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on Other RoA - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Other RoA - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by Application ($ billion)
Exhibits47: Data Table on Market opportunity by Application ($ billion)
Exhibits48: Chart on Type - Market share 2023-2028 (%)
Exhibits49: Data Table on Type - Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by Type
Exhibits51: Data Table on Comparison by Type
Exhibits52: Chart on PDE5 inhibitors - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on PDE5 inhibitors - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on PDE5 inhibitors - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on PDE5 inhibitors - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on PDE4 inhibitors - Market size and forecast 2023-2028 ($ billion)
Exhibits57: Data Table on PDE4 inhibitors - Market size and forecast 2023-2028 ($ billion)
Exhibits58: Chart on PDE4 inhibitors - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on PDE4 inhibitors - Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on PDE3 and others - Market size and forecast 2023-2028 ($ billion)
Exhibits61: Data Table on PDE3 and others - Market size and forecast 2023-2028 ($ billion)
Exhibits62: Chart on PDE3 and others - Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on PDE3 and others - Year-over-year growth 2023-2028 (%)
Exhibits64: Market opportunity by Type ($ billion)
Exhibits65: Data Table on Market opportunity by Type ($ billion)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on France - Market size and forecast 2023-2028 ($ billion)
Exhibits104: Data Table on France - Market size and forecast 2023-2028 ($ billion)
Exhibits105: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ billion)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits109: Impact of drivers and challenges in 2023 and 2028
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: Amgen Inc. - Overview
Exhibits116: Amgen Inc. - Product / Service
Exhibits117: Amgen Inc. - Key offerings
Exhibits118: AstraZeneca Plc - Overview
Exhibits119: AstraZeneca Plc - Product / Service
Exhibits120: AstraZeneca Plc - Key news
Exhibits121: AstraZeneca Plc - Key offerings
Exhibits122: Bayer AG - Overview
Exhibits123: Bayer AG - Business segments
Exhibits124: Bayer AG - Key news
Exhibits125: Bayer AG - Key offerings
Exhibits126: Bayer AG - Segment focus
Exhibits127: Boehringer Ingelheim International GmbH - Overview
Exhibits128: Boehringer Ingelheim International GmbH - Business segments
Exhibits129: Boehringer Ingelheim International GmbH - Key news
Exhibits130: Boehringer Ingelheim International GmbH - Key offerings
Exhibits131: Boehringer Ingelheim International GmbH - Segment focus
Exhibits132: Dong A Socio Holdings Co. Ltd. - Overview
Exhibits133: Dong A Socio Holdings Co. Ltd. - Product / Service
Exhibits134: Dong A Socio Holdings Co. Ltd. - Key offerings
Exhibits135: Dr Reddys Laboratories Ltd. - Overview
Exhibits136: Dr Reddys Laboratories Ltd. - Business segments
Exhibits137: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits138: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits139: Eli Lilly and Co. - Overview
Exhibits140: Eli Lilly and Co. - Product / Service
Exhibits141: Eli Lilly and Co. - Key news
Exhibits142: Eli Lilly and Co. - Key offerings
Exhibits143: GlaxoSmithKline Plc - Overview
Exhibits144: GlaxoSmithKline Plc - Business segments
Exhibits145: GlaxoSmithKline Plc - Key news
Exhibits146: GlaxoSmithKline Plc - Key offerings
Exhibits147: GlaxoSmithKline Plc - Segment focus
Exhibits148: Pfizer Inc. - Overview
Exhibits149: Pfizer Inc. - Product / Service
Exhibits150: Pfizer Inc. - Key news
Exhibits151: Pfizer Inc. - Key offerings
Exhibits152: Sanofi SA - Overview
Exhibits153: Sanofi SA - Business segments
Exhibits154: Sanofi SA - Key news
Exhibits155: Sanofi SA - Key offerings
Exhibits156: Sanofi SA - Segment focus
Exhibits157: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits158: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits159: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits160: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits161: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits162: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits163: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits164: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits165: United Therapeutics Corp. - Overview
Exhibits166: United Therapeutics Corp. - Product / Service
Exhibits167: United Therapeutics Corp. - Key offerings
Exhibits168: Viatris Inc. - Overview
Exhibits169: Viatris Inc. - Business segments
Exhibits170: Viatris Inc. - Key news
Exhibits171: Viatris Inc. - Key offerings
Exhibits172: Viatris Inc. - Segment focus
Exhibits173: Zydus Lifesciences Ltd. - Overview
Exhibits174: Zydus Lifesciences Ltd. - Business segments
Exhibits175: Zydus Lifesciences Ltd. - Key offerings
Exhibits176: Zydus Lifesciences Ltd. - Segment focus
Exhibits177: Inclusions checklist
Exhibits178: Exclusions checklist
Exhibits179: Currency conversion rates for US$
Exhibits180: Research methodology
Exhibits181: Validation techniques employed for market sizing
Exhibits182: Information sources
Exhibits183: List of abbreviations